Bioequivalence Study Between Two Oral Formulations of Famotidine Tablets Under Fed Conditions
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Layout table for eligibility information
Ages Eligible for Study:
18 Years and older (Adult, Older Adult)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
healthy men or women 18 years of age or older
body mass index below 30.0 kg/m2
willing to participate and sin a copy of the informed consent form
recent history of drug or alcohol addiction or abuse
pregnant or lactating women
history of allergic response to heparin, famotidine, other H2-receptor antagonists, or other related drugs
evidence of a clinically significant disorder or whose laboratory results were deemed to be clinically significant